✦ LIBER ✦

Safety and tolerance of single oral doses of trandolapril (RU 44.570), a new angiotensin converting enzyme inhibitor

✍ Scribed by A. Patat; A. Surjus; A. Go; J. Granier

Book ID: 104810472
Publisher: Springer
Year: 1989
Tongue: English
Weight: 610 KB
Volume: 36
Category: Article
ISSN: 0031-6970
DOI: 10.1007/bf00561017

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A double-blind study to compare the effi

A double-blind study to compare the efficacy, tolerance and safety of two doses of the angiotensin converting enzyme inhibitor ramipril with placebo

✍ Alberto S. Villamil; Victoria Cairns; Peter U. Witte; Carlos A. Bertolasi 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 505 KB

Pharmacokinetics of a new angiotensin I

Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states

✍ Onoyama, Kaoru; Hirakata, Hideki; Tsuruda, Hiroshi; Ohchi, Nobuaki; Tomooka, Sug 📂 Article 📅 1985 🏛 Nature Publishing Group 🌐 English ⚖ 333 KB

Efficacy, tolerance and hormonal effects

Efficacy, tolerance and hormonal effects of a new oral angiotensin converting enzyme inhibitor, ramipril (HOE 498), in mild to moderate primary hypertension

✍ Bengt E. Karlberg; Torbjörn Lindström; Ulf Rosenqvist; K.Peter Öhman 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 682 KB

Valsartan, a new angiotensin II antagoni

Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: efficacy, tolerability and safety compared to an angiotensin-converting enzyme inhibitor, lisinopril

✍ Black, H R; Graff, A; Shute, D; Stoltz, R; Ruff, D; Levine, J; Shi, Y; Mallows, 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 272 KB

Safety and Tolerability of Angiotensin-C

Safety and Tolerability of Angiotensin-Converting Enzyme Inhibitor Versus the Combination of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Patients With Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

✍ Rachid Lakhdar; Mouaz H. Al-Mallah; David E. Lanfear 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 257 KB

Disposition of pentopril, a new orally a

Disposition of pentopril, a new orally active angiotensin-converting enzyme inhibitor, and its active metabolite in rats

✍ Ashok Rakhit; Gregory Kochak; Ronald Dotson; Vijay Tipnis 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

The disposition characteristics of pentopril (the ethyl ester) and its active carboxylic acid metabolite (CGS 13934) were determined in conscious rats after separate intravenous administrations of both compounds. The relationship between plasma concentration and pharmacological effect was also evalu